Clinical Trial Update: Magnesium Supplementation in People With XMEN Syndrome [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating magnesium supplementation in XMEN syndrome has completed with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Xmen Syndrome

Drugs mentioned

• Magnesium supplementation (magnesium)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: XMEN | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-01-26